Artifacts in the analysis of thioridazine and other neuroleptics.
Although the sensitivity to light of thioridazine and its metabolites has been described, the problem does not seem to be widely acknowledged. Indeed, a survey of the literature shows that assays of these compounds under light-protected conditions have been performed only in a few of the numerous analytical studies on this drug. In the present study, thioridazine, its metabolites, and 18 other neuroleptics were tested for their sensitivity to light under conditions used for their analysis. The results show that light significantly affects the analysis of thioridazine and its metabolites. It readily causes the racemization of the isomeric pairs of thioridazine 5-sulphoxide and greatly decreases the concentration of thioridazine. This sensitivity to light varied with the medium used (most sensitive in acidic media) and also with the molecule (in order of decreasing sensitivity: thioridazine > mesoridazine > sulforidazine). Degradation in neutral or basic media was slow, with the exception of mesoridazine in a neutral medium. Twelve other phenothiazines tested, as well as chlorprotixene, a thioxanthene drug, were found to be sensitive to light in acidic media, whereas flupenthixol and zuclopenthixol (two thioxanthenes), clozapine, fluperlapine, and haloperidol (a butyrophenone) did not seem to be affected. In addition to being sensitive to light, some compounds may be readily oxidized by peroxide-containing solvents.
Eap
C B
CB
Département Universitaire de Psychiatrie Adulte (DUPA), Prilly-Lausanne, Switzerland.
Koeb
L
L
Baumann
P
P
D014150:Antipsychotic Agents / Q000032:analysis*; D016477:Artifacts; D004355:Drug Stability; D006801:Humans; D012016:Reference Values; D013237:Stereoisomerism; D013472:Sunlight; D013881:Thioridazine / Q000032:analysis / Q000097:blood* / Q000378:metabolism
D014150:Antipsychotic Agents; D013881:Thioridazine